
Ground-Breaking Clinical Trial at VCU in Richmond, VA
Vertex Pharmaceuticals has launched a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D)…
Vertex Pharmaceuticals has launched a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D)…
We value your privacy. When you visit BreakthroughT1D.org (and our family of websites), we use cookies to process your personal data in order to customize content and improve your site experience, provide social media features, analyze our traffic, and personalize advertising. By choosing “I Agree”, you understand and agree to Breakthrough T1D's Privacy Policy
We value your privacy. When you visit BreakthroughT1D.org (and our family of websites), we use cookies to process your personal data in order to customize content and improve your site experience, provide social media features, analyze our traffic, and personalize advertising. By choosing “I Agree”, you understand and agree to Breakthrough T1D's Privacy Policy